AGP Executive Report
Last update: 2 hours agoDrug Manufacturing & Compliance: The U.S. FDA declined to approve Cingulate’s ADHD treatment CTx-1301, citing manufacturing-related concerns tied to its contract manufacturer, after earlier disclosures of FDA observations. Advanced Manufacturing for Defense: ACMI and EOS announced a partnership to scale additive manufacturing for U.S. defense, including ACMI’s purchase of multiple EOS metal systems. CNC & Productivity Tech: FANUC launched the Series 500i-A CNC platform for machine builders, touting major CPU performance gains, faster cycle times, and upgraded 5-axis machining features. Additive Materials: Electroninks introduced an air-curable copper metallization ink for additive manufacturing, aiming to remove the inert-atmosphere constraint for large-area copper processing. Quality & Inspection: FLIR highlighted thermal-imaging inspection for filling and sealing in food and beverage lines to catch defects beyond visual checks. Industrial Policy & Jobs: Ghana signaled a manufacturing reset at a UK investment summit, pitching agro-processing and a West Africa Hyundai automotive manufacturing plant. Security & Industrial Capacity: Lockheed Martin opened a new NGI missile production facility in Alabama to accelerate homeland interceptor manufacturing. Regional Manufacturing Signals: Kazakhstan’s PMI showed early April stabilization but stayed in contraction, with cost inflation re-accelerating. Local Manufacturing Growth: Unison Ltd completed its acquisition of PHI Hydraulics to expand tube and pipe end-forming capabilities. Public Safety & Illicit Production: Mumbai police seized a suspected mephedrone manufacturing unit in Gujarat, recovering narcotics, chemicals, and equipment worth about Rs 74.76 crore.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.